
TPG Growth
Description
TPG Growth is the dedicated growth equity and middle-market buyout platform of TPG, a leading global alternative asset firm headquartered in San Francisco. The firm specializes in providing capital to companies with established business models that are poised for significant expansion. TPG Growth leverages TPG's extensive operational expertise, industry insights, and global network to accelerate the growth and value creation of its portfolio companies.
The platform's investment strategy is broad, encompassing sectors such as technology, healthcare, consumer, and industrials. TPG Growth seeks to partner with management teams, offering flexible capital solutions that range from minority growth investments to control buyouts. Their approach focuses on identifying companies with strong fundamentals and providing strategic guidance, operational support, and access to TPG's vast ecosystem to help these businesses scale, innovate, and achieve market leadership.
TPG Growth manages substantial capital, enabling significant investments. For instance, its TPG Growth VI fund successfully closed in 2023 with $4.6 billion in commitments, following the $5.3 billion TPG Growth V fund in 2019. These substantial fund sizes allow TPG Growth to deploy significant capital into its portfolio. Typical first checks for TPG Growth generally range from approximately $50 million to $300 million, though larger investments can occur, particularly in co-investment scenarios or for significant control transactions where the firm acts as a lead investor.
Investor Profile
TPG Growth has backed more than 129 startups, with 3 new investments in the last 12 months alone. The firm has led 65 rounds, about 50% of its total and boasts 51 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Private Equity, Series C, Series B rounds (top funding stages).
- Majority of deals are located in United States, India, Israel.
- Strong thematic focus on Health Care, Software, Biotechnology.
- Led 3 rounds in the past year.
- Typical check size: $50M – $300M.
Stage Focus
- Private Equity (17%)
- Series C (16%)
- Series B (16%)
- Series A (13%)
- Series D (10%)
- Series Unknown (7%)
- Secondary Market (5%)
- Series E (5%)
- Debt Financing (3%)
- Series F (3%)
Country Focus
- United States (61%)
- India (22%)
- Israel (4%)
- China (3%)
- United Kingdom (2%)
- Germany (2%)
- Kenya (1%)
- Brazil (1%)
- Philippines (1%)
- Bangladesh (1%)
Industry Focus
- Health Care
- Software
- Biotechnology
- Information Technology
- E-commerce
- Saas
- Pharmaceutical
- Financial Services
- Enterprise Software
- Health Diagnostics
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.